Cargando…
Safety of 3‐Month Dual Antiplatelet Therapy After Implantation of Ultrathin Sirolimus‐Eluting Stents With Biodegradable Polymer (Orsiro): Results From the SMART‐CHOICE Trial
BACKGROUND: This study sought to investigate the safety of 3‐month dual antiplatelet therapy (DAPT) in patients receiving ultrathin sirolimus‐eluting stents with biodegradable polymer (Orsiro). METHODS AND RESULTS: The SMART‐CHOICE (Smart Angioplasty Research Team: Comparison Between P2Y12 Antagonis...
Autores principales: | Yun, Kyeong Ho, Lee, Seung‐Yul, Cho, Byung Ryul, Jang, Woo Jin, Song, Young Bin, Oh, Ju‐Hyeon, Chun, Woo Jung, Park, Yong Hwan, Im, Eul‐Soon, Jeong, Jin‐Ok, Oh, Seok Kyu, Cho, Deok‐Kyu, Lee, Jong‐Young, Koh, Young‐Youp, Bae, Jang‐Whan, Choi, Jae Woong, Lee, Wang Soo, Yoon, Hyuck Jun, Lee, Seung Uk, Cho, Jang Hyun, Choi, Woong Gil, Rha, Seung‐Woon, Lee, Joo Myung, Park, Taek Kyu, Yang, Jeong Hoon, Choi, Jin‐Ho, Choi, Seung‐Hyuck, Lee, Sang Hoon, Gwon, Hyeon‐Cheol, Hahn, Joo‐Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955499/ https://www.ncbi.nlm.nih.gov/pubmed/33345567 http://dx.doi.org/10.1161/JAHA.120.018366 |
Ejemplares similares
-
P2Y(12) inhibitor monotherapy in complex percutaneous coronary intervention: A post-hoc analysis of SMART-CHOICE randomized clinical trial
por: Roh, Ji Woong, et al.
Publicado: (2021) -
Three‐year clinical outcome of biodegradable hybrid polymer Orsiro sirolimus‐eluting stent and the durable biocompatible polymer Resolute Integrity zotarolimus‐eluting stent: A randomized controlled trial
por: Kim, Soo‐Hyun, et al.
Publicado: (2019) -
Duration of dual antiplatelet therapy in patients treated with percutaneous coronary intervention for coronary chronic total occlusion
por: Lee, Seung Hwa, et al.
Publicado: (2017) -
Clinical Implications of Early Exercise Treadmill Testing after Percutaneous Coronary Intervention in the Drug-eluting Stent Era
por: Cho, Sung Woo, et al.
Publicado: (2020) -
Long-term Outcomes of Clopidogrel Monotherapy versus Prolonged Dual Antiplatelet Therapy beyond 12 Months after Percutaneous Coronary Intervention in High-risk Patients
por: Kim, Dong-Yeon, et al.
Publicado: (2021)